Skip to content
Search

Latest Stories

Novo Nordisk launches recycling for injection pens with community pharmacies playing key role

Novo Nordisk has launched PenCycle, a recycling initiative for pre-filled injection pens, designed to address the challenge of recycling injection pen devices.

A first-of-its-kind scheme in the UK, covering FlexPen® and FlexTouch® used to dispense insulin and other medications, will have community pharmacies playing a key role.


Users can return their devices to local participating community pharmacies or through pre-paid Royal Mail boxes or use an ‘at home’ collection pilot service for growth hormone pens.

The pens will then be returned to Denmark where the plastic will be recycled into a range of items, such as chairs and lamps, the Danish multinational pharmaceutical company said.

PenCycle return box

As part of the initiative, participating pharmacies will be provided a PenCycle Starter Pack, containing all necessary materials, including practical guidance on the initiative, patient information and materials for patients to take home and start PenCycling.

The pilot will launch initially across Greater Manchester, Leicestershire & Rutland, and Greater Glasgow and Clyde, ahead of a planned national roll-out next year.

The pilot alone aims to recycle over 150,000 pre-filled plastic injection pen devices, ensuring over two tonnes of plastic material is diverted from the UK landfill.

By the end of 2022, it aims to recycle 1.1 million pen devices.

According to the company, the project has a potential to recycle over 3 million pen devices in 2023, preventing over 56 tonnes of plastic waste.

Pinder Sahota, general manager UK, Novo Nordisk said: “As part of our Circular for Zero initiative, we were the first pharmaceutical company to run all of our production through renewable power, and now we are taking on the challenge of recycling our plastic pen devices.

"To provide convenient options to people we have focused on establishing partnerships with community pharmacies and the Royal Mail.

“Through this recycling initiative we can help to give used pens a new purpose, and play our part in preventing further waste.”

Laura Sims, head of membership for the National Pharmacy Association, said: “We’re pleased to be supporting the PenCycle collaboration, and helping our members understand the benefits of the pilot scheme and how to take part.

"Community pharmacies dispense more than a billion prescription items each year and can greatly increase sustainability through recycling.”

Expressing delight over supporting the PenCycle initiative, Kevin Birch, chief retail officer at LloydsPharmacy, said his company is "committed to becoming a sustainable business, and we understand that our customers and patients expect us to play our part. Reducing plastic waste in our healthcare settings is a key part of our approach.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less